# FDA Inspection 1103556 - Beigene USA, Inc. - September 13, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/beigene-usa-inc/fe3b6584-4411-4689-9a6d-347b68889735
Source feed: FDA_Inspections

> FDA Inspection 1103556 for Beigene USA, Inc. on September 13, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1103556
- Company Name: Beigene USA, Inc.
- Inspection Date: 2019-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1167967 - 2022-04-08](https://www.globalkeysolutions.net/records/fda_inspections/beigene-usa-inc/e9eb397b-b21d-480a-8357-432da7c556d2)
- [FDA Inspection 1156036 - 2021-10-22](https://www.globalkeysolutions.net/records/fda_inspections/beigene-usa-inc/68e296f0-ceed-4cc5-a613-8f8abcf241fe)
- [FDA Inspection 1143711 - 2021-06-02](https://www.globalkeysolutions.net/records/fda_inspections/beigene-usa-inc/b7644873-1752-413d-bd1e-ffdd0e245aae)

Company: https://www.globalkeysolutions.net/companies/beigene-usa-inc/6ed31dc5-4a6b-46ea-8a4f-ada9376db039

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c